• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

July 2, 2018
Company Drug/Device Medical Condition Status
Oramed Pharmaceuticals Inc. ORMD-0801 type 1 diabetes Phase I trial initiated
Erimos Pharmaceuticals, LLC terameprocol (EM-1421) High Grade Glioma (Grade III or IV) Phase I trial initiated
BioGend Therapeutics one-step autologous knee cartilage repair/regeneration repair treatment for knee chondral or osteochondral defects Phase I trial initiated enrolling 92 subjects
Rigel Pharmaceuticals, Inc. R835 (IRAK1/4 inhibitor) autoimmune and inflammatory diseases Phase I trial initiated enrolling 91 subjects
Navitor Pharmaceuticals, Inc. NV-5138 treatment-resistant depression (TRD) Phase I trial initiated enrolling 88 subjects
Axonics Modulation Technologies, Inc. rechargeable Sacral Neuromodulation (r-SNM) System urinary and bowel disfunction Phase I trial initiated enrolling 120 subjects
BioAtla, LLC BA3021 (CAB-ROR2-ADC therapeutic) advanced solid tumors including non-small cell lung cancer (NSCLC), triple negative breast cancer and soft tissue sarcoma Phase I/II trial initiated
Roche and Genentech TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and etoposide) Extensive-stage small cell lung cancer (ES-SCLC) Phase III trial initiated enrolling 403 subjects in the U.S.
Beckman Coulter Diagnostics Access hsTnl (high-sensitivity troponin assay) myocardial infarction 510(k) Clearance granted by the FDA
Renovis Surgical Technologies, Inc. Tesera SA Hyperlordotic ALIF Interbody Spinal Fusion System spinal fusion 510(k) Clearance granted by the FDA
Genentech Baloxavir marboxil single-dose oral flu treatment for people 12 years and older Priority Review and NDA approval granted by the FDA
Merck & Company KEYTRUDA (pembrolizumab) adjuvant therapy in advanced melanoma sBLA accepted by the FDA
Glaukos Corporation iStent inject Trabecular Micro-Bypass System reduction of intraocular pressure (IOP) in adult mild-to-moderate primary open-angle glaucoma (POAG) patients undergoing concomitant cataract surgery Approval granted by the FDA
Ferring Pharmaceuticals Inc. NOCDURNA (desmopressin acetate) treatment of nocturne due to nocturnal polyuria in adults who awaken at least two times per night to void Approval granted by the FDA
Achaogen Zemdri (plazomicin) complicated urinary tract infection Approval granted by the FDA
Array BioPharma, Inc. Braftovi + Mektovi BRAF-mutant metastatic melanoma Approval granted by the FDA
Processa Pharmaceuticals, Inc. PCS499 Necrobiosis Lipoidica (NL) Orphan Drug Designation granted by the FDA

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing